June 16, 2026 FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
June 16, 2026 HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit with the Schall Law Firm
